![](https://www.pharmavoice.com/imgproxy/_A0mlgK0LsUd7zgBZS-GDaV1MdTA-sllqp4NQ_CHFZk/g:nowe:0:0/c:1781:1006/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL1NjcmVlbnNob3RfMjAyMy0wOS0xOV8xNDI0MjYucG5n.webp)
As feds crack down on PBMs for drug costs, Big Pharma could lose some of the heat
Pharma executives and lobbyists have long sought to shift the blame for U.S. drug costs to the industry’s price-negotiating middlemen. Now, with the release of an FTC report this week pointing out the “enormous power and influence” these pharmacy benefit …